Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

113.19 +0.69 (+0.61%)
Streaming Delayed Price Updated: 2:07 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Zimmer Holdings

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (Nasdaq - ACCD), Paragon 28, Inc. (NYSE - FNA), Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN)
From Brodsky & Smith LLC
Via GlobeNewswire
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. 
Via MarketBeat
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia 
Via MarketBeat
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. 
Via MarketBeat
Topics Supply Chain
Exposures Supply Chain
Why Intuitive Surgical Stock is Dominating the Medical Sector
Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However 
Via MarketBeat
Intuitive Surgical Leads the Robotic Surgery Movement
Intuitive Surgical is the pioneer in robotic-assisted surgery, investors hope the fifth generation of its da Vinci system can push ISRG stock higher 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Hidden gems: 3 undervalued stocks with a unique competitive edge
Etsy, International Flavors & Fragrances and Zimmer Biomet are undervalued stocks with unique market advantages. Patient investors may find opportunities here. 
Via MarketBeat
Is the Ozempic-Driven DexCom Selloff Overdone?
Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly? 
Via MarketBeat
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth. 
Via MarketBeat
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
Via MarketBeat
Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher
Shockwave got a 10.64% jolt on a proposed Medicare change that could up the usage of its gear. Other medical product makers are forming bullish consolidations. 
Via MarketBeat
Zimmer Biomet Beats on Earnings, Growth May be Priced In
Zimmer Biomet stock is gaining after beating expectations. However, ZBH stock was fairly valued before earnings meaning investors may need to wait on analysts 
Via MarketBeat
Is Zimmer Biomet a Buy Ahead of Earnings?
Zimmer will report Q4'22 earnings this week. The question on people's minds is if it's a buy prior to this announcement being made. 
Via MarketBeat
Exposures COVID-19
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.